When was Savran Technologies founded?

Savran Technologies was founded in 2018 and raised its 1st funding round within a year of its incorporation.

Where is Savran Technologies located?

Savran Technologies is headquartered in Cambridge, United States.

Who is the current CEO of Savran Technologies?

Cagri Savran of Savran Technologies.

How many employees does Savran Technologies have?

As of Mar 31, 2026, the latest employee count at Savran Technologies is 9.

Is Savran Technologies a funded company?

Savran Technologies is a funded company, having raised a total of $5.91M across 9 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 25, 2018.

When was the latest funding round of Savran Technologies?

Savran Technologies' latest funding was a $***** Series A round on Aug 16, 2024, with participation from 0 investor.

Where does Savran Technologies rank among its competitors?

Savran Technologies ranks 116th amongst 428 active competitors, of which 129 are funded. It stands 19th in terms of total funding among its competitors. The most recent competitor to raise funding was Delfi Diagnostics, which secured $34.3M in Dec, 2025.

Who are the top competitors of Savran Technologies?

Savran Technologies' top competitors include Guardant Health, Natera and Exact Sciences. Among them, Delfi Diagnostics secured the most recent funding round in December, 2025.

Savran Technologies - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of non-invasive rare cell detection platform. The company has developed a technology to isolate ultra-rare cells from the blood. Their technology is used for monitoring cancer patient's progress, as well as looking early into pregnancy to gain a complete genetic picture of the fetus.

Website: savrantech.com
Email ID: *****@savrantech.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Cambridge, United States

Stage

Series A

Total Funding

$5.91M in 9 rounds

Latest Funding Round

Series A, Aug 16, 2024, $*****

Ranked

116^th among 428 active competitors

Employee Count

9 as on Mar 31, 2026

Similar Companies

Guardant Health & 551 more

View Savran Technologies' full profile

Savran Technologies has raised a total funding of $5.91M over 9 rounds. Its first funding round was on Jan 25, 2018.

Here is the list of recent funding rounds of Savran Technologies:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 16, 2024	4216348	Series A	8404240	6825570	2384836	5071689
Mar 07, 2023	4733761	Conventional Debt	1040623	2843766	5425072	4268563
Dec 10, 2021	7698917	Series A	6237949	2198381	8766504	1680362

Access funding benchmarks and valuations. Sign up today!

View details of Savran Technologies's funding rounds and investors

The founders of Savran Technologies is Cagri Savran.

Here are the details of Savran Technologies' key team members:

Cagri Savran: Founder & CEO of Savran Technologies.

View details of Savran Technologies's Founder profiles and Board Members

Savran Technologies' employee count trend

Savran Technologies has 9 employees as of Mar 26. Here is Savran Technologies's employee count trend over the years:

Employee count trend for Savran Technologies

Uncover Savran Technologies' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Savran Technologies include Guardant Health, Natera and Exact Sciences. Here is the list of Top 10 competitors of Savran Technologies, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	Orbimed, SoftBank Vision Fund & 24 others	80/100
2nd	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	HRC Fertility, HHS & 16 others	78/100
3rd	Exact Sciences 1995, Madison (United States), Public	Provider of non-invasive molecular diagnostic testing solutions for cancer	-	Petrillo Capital, Back Bay Group & 8 others	73/100
4th	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	HHS, Grayhawk Capital & 6 others	72/100
5th	BillionToOne 2015, San Francisco (United States), Public	Provider of cell-free cancer liquid biopsy test	$389M	Hummingbird Ventures, Adams Street Partners ... & 29 others	71/100
6th	Foundation Medicine 2010, Cambridge (United States), Acquired	Provider of genomics-based diagnostics test for cancer	$96.5M	Deerfield, Redmile Group & 11 others	71/100
7th	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Coatue, Braidwell & 19 others	70/100
8th	Prenetics 2009, Hong Kong (China), Public	Online platform for genetic and diagnostic health testing that helps identify health risks	$67.6M	Beyond Ventures, Ping An Ventures & 21 others	70/100
9th	Delfi Diagnostics 2019, Baltimore (United States), Series B	Provider of DNA sequencing for cancer detection	$332M	Orbimed, DFJ Growth & 17 others	68/100
10th	ImaginAb 2007, Los Angeles (United States), Series C	Immune imaging technology for cancer and autoimmune disease management	$59.6M	Theravance Biopharma, Merieux Equity Partners ... & 12 others	65/100
116th	Savran Technologies 2018, Cambridge (United States), Series A	Provider of non-invasive rare cell detection platform	$5.91M	-	39/100